Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
Article
CAS
PubMed
Google Scholar
Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KCH (1999) The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 81:80–86
Article
CAS
PubMed
Google Scholar
Bruera E, Strasser F, Palmer JL, Willey J, Calder K, Amyotte G, Baracos V (2003) Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol 21:129–134
Article
Google Scholar
Capra S, Bauer J, Davidson W, Ash S (2002) Nutritional therapy for cancer-induced weight loss. Nutr Clin Pract 17:210–213
Google Scholar
Davidson W, Ash S, Capra S, Bauer J, Cancer Cachexia Study Group (2004) weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer. Clin Nutr 23:239–247
Article
PubMed
Google Scholar
Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy KN (1987) What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 11:8–13
CAS
PubMed
Google Scholar
DeWys WD, Begg C, Lavin PT, et al (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69:491–497
CAS
PubMed
Google Scholar
Fearon KCH, von Meyenfeldt MF, Moses AGW, van Geenen R, Roy A, Gouma DJ, Giacose A, Van Gossum A, Bauer J, Barber M, Aaronson NK, Voss AC, Tisdale M (2003) The effect of a protein and energy dense, n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52:1479–1486
Article
CAS
PubMed
Google Scholar
Forbes GB (1962) Methods for determining composition of the human body. Paediatrics 29:477–494
CAS
Google Scholar
Isenring E, Bauer J, Capra S (2003) The scored Patient-generated Subjective Global Assessment (PG-SGA) and its association with quality of life in ambulatory patients receiving radiotherapy. Eur J Clin Nutr 57:305–309
Article
CAS
PubMed
Google Scholar
Jatoi A, Rowland K, Loprinzi CL, Sloan JA, Dakhil SR, MacDonald N, Gagnon B, Novotny PJ, Mailliard JA, Bushey TI, Nair S, Christensen B; North Central Cancer Treatment Group (2004) An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 15:2469–2476
Article
Google Scholar
Martin C (2000) Calorie, protein, fluid, and micronutrient requirements. In: McCallum PD, Polisena CG (eds) The clinical guide to oncology nutrition. The American Dietetic Association, Chicago, pp 45–52
McCarthy D, Weihofen D (1999) The effect of nutritional supplements on food intake in patients undergoing radiotherapy. Oncol Nurs Forum 26:897–900
CAS
PubMed
Google Scholar
Moses AWG, Slater C, Preston T, Barber MD, Fearon KCH (2004) Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90:996–1002
Article
CAS
PubMed
Google Scholar
Nitenberg G, Raynard B (2000) Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol 34:137–168
CAS
PubMed
Google Scholar
Oettle H, Arnold D, Hempel C, Riess H (2000) The role of gemcitabine alone and in combination in the treatment of pancreatic cancer. Anticancer Drugs 11:771–786
Article
CAS
PubMed
Google Scholar
Ottery FD (1996) Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 12 [1 Suppl]:S15–19
Splett PL (1996) Cost outcomes of nutrition intervention: part 2. Mead Johnson, New York
Google Scholar
Stratton RJ, Elia M (1999) A critical, systematic analysis of the use of oral nutritional supplements in the community. Clin Nutr 18:S29–84
Google Scholar
Vansteenkiste JF, Vandebroek JE, Nackaerts KL, Weynants P, Valcke YJ, Verresen DA, Devogelaere RC, Marien SA, Humblet YP, Dams NL; Leuven Lung Cancer Group (2001) Clinical-benefit response in advanced non-small-cell lung cancer: a multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine. Ann Oncol 12:1221–1230
Article
CAS
PubMed
Google Scholar